Fisher Asset Management LLC Has $24.55 Million Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Fisher Asset Management LLC lowered its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 0.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 314,386 shares of the company’s stock after selling 3,007 shares during the period. Fisher Asset Management LLC owned 0.64% of Prestige Consumer Healthcare worth $24,550,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. boosted its position in Prestige Consumer Healthcare by 3.2% in the third quarter. JPMorgan Chase & Co. now owns 272,255 shares of the company’s stock valued at $19,630,000 after buying an additional 8,533 shares in the last quarter. Geode Capital Management LLC boosted its position in Prestige Consumer Healthcare by 4.0% in the third quarter. Geode Capital Management LLC now owns 1,326,794 shares of the company’s stock valued at $95,678,000 after buying an additional 50,961 shares in the last quarter. Avior Wealth Management LLC boosted its position in Prestige Consumer Healthcare by 1,570.7% in the fourth quarter. Avior Wealth Management LLC now owns 8,554 shares of the company’s stock valued at $668,000 after buying an additional 8,042 shares in the last quarter. Barclays PLC boosted its position in Prestige Consumer Healthcare by 346.3% in the third quarter. Barclays PLC now owns 92,444 shares of the company’s stock valued at $6,665,000 after buying an additional 71,730 shares in the last quarter. Finally, Assenagon Asset Management S.A. boosted its position in Prestige Consumer Healthcare by 171.6% in the fourth quarter. Assenagon Asset Management S.A. now owns 46,931 shares of the company’s stock valued at $3,665,000 after buying an additional 29,649 shares in the last quarter. Institutional investors and hedge funds own 99.95% of the company’s stock.

Wall Street Analyst Weigh In

PBH has been the topic of a number of recent research reports. Raymond James upgraded shares of Prestige Consumer Healthcare to a “moderate buy” rating in a report on Thursday, December 19th. StockNews.com upgraded shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Friday, January 24th. Canaccord Genuity Group lifted their price target on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a report on Friday, February 7th. Sidoti lowered shares of Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price target on the stock. in a report on Monday, December 9th. Finally, Oppenheimer lifted their price target on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an “outperform” rating in a report on Thursday, February 13th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $92.60.

Prestige Consumer Healthcare Price Performance

Shares of NYSE PBH opened at $85.34 on Tuesday. Prestige Consumer Healthcare Inc. has a twelve month low of $62.35 and a twelve month high of $88.36. The firm has a fifty day simple moving average of $80.18 and a 200 day simple moving average of $77.40. The company has a market capitalization of $4.23 billion, a PE ratio of 19.99, a P/E/G ratio of 2.69 and a beta of 0.50. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56.

Prestige Consumer Healthcare (NYSE:PBH) last announced its earnings results on Thursday, February 6th. The company reported $1.22 earnings per share for the quarter, topping analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. On average, sell-side analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.